Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Onbrez Breezhaler, Arcapta Neohaler
Indacaterol is a long-acting beta2-adrenergic agonist (LABA) used in the maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It works by relaxing the muscles in the airways, making it easier to breathe. Indacaterol is typically administered once daily using a dry powder inhaler.
For maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and emphysema.
Outcome:
Reduced bronchodilator effect, potential for bronchospasm
Mechanism:
Pharmacodynamic antagonism
Outcome:
Additive effects and increased risk of adverse events
Mechanism:
Similar mechanism of action
Outcome:
Potential for bronchospasm in aspirin-sensitive individuals
Mechanism:
Inhibition of prostaglandin synthesis
Most likely new formulation: combination inhaler with a long-acting muscarinic antagonist (2025, 70% confidence)
Based on current usage trends and clinical trial data, there is a low likelihood of any major regulatory changes in the near future (<5% within the next 2 years).
Bronchodilator, Beta2-adrenergic agonist
Indanylcarboxamide